Humana Inc vs iShares 0 3 Month Treasury Bond ETF — how do they compare? Humana Inc trades at $437.2 (market cap $47.61B), while iShares 0 3 Month Treasury Bond ETF trades at $100.56 (market cap $114.04B). The key difference: iShares 0 3 Month Treasury Bond ETF is far larger — about 2.4× Humana Inc's market cap, and Humana Inc pays a 0.89% dividend while iShares 0 3 Month Treasury Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and iShares 0 3 Month Treasury Bond ETF for 50 Days on average.
| HUM | SGOV | |
|---|---|---|
Market Cap | $47.61B | $114.04B |
Volume | 1,827,332 | 19,563,576 |
Sector | Health | Fixed Income |
52-Week High | $409.85 | $100.72 |
52-Week Low | $163.67 | $100.28 |
Typical Hold Time | 53 Days | 50 Days |
Enterprise Value | $54.97B | — |
Dividend Yield | 0.89% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
SGOV (iShares 0-3 Month Treasury Bond ETF) trades at $100.465 with minimal daily movement, reflecting its stable Treasury bill focus. The ETF shows bearish technical signals with 17 sell indicators versus 4 buys, though RSI levels suggest potential oversold conditions. Recent institutional selling by Envestnet Asset Management (-13.2% in Q2 2026) contrasts with consistent dividend distributions around $0.30-0.31 monthly.
SGOV provides stable income exposure to short-term US Treasuries amid rising bond yields, but faces headwinds from the ongoing bond market rout. The ETF's defensive positioning appeals to income-focused investors, though continued yield increases could pressure near-term performance. Current technical weakness suggests cautious entry points may emerge.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →SGOV provides exposure to ultra-short-term U.S. Treasury bills with maturities of three months or less. It functions as a high-liquidity cash alternative, seeking to provide current income while maintaining a stable net asset value and minimal interest rate risk.
Read more on SGOV →